Wildlife-rich woods that stimulate the senses boost wellbeing, major study shows
Woods rich in the sights, sounds and smells of nature can be a 'prescription' for wellbeing – but there are major disparities in being able to access them, a study shows.
Some 90% of 10,000 people questioned for a study backed by the Woodland Trust agreed that woodland biodiversity has a positive impact on their wellbeing.
Researchers from the University of Kent who conducted the study said a rich variety of wildlife and sensory experiences they deliver for visitors, from birdsong to the colours in a wood, the sounds of the wind in the trees and even the feeling of the ground underfoot, were critical to boosting wellbeing.
But the richest woods are very unevenly distributed across the UK, with hotspots in the South East and Scotland where there are a higher proportion of ancient and long-standing woodland cover, and areas with higher deprivation often lacking in thriving habitats.
Conservationists said the findings showed the need to restore British woodlands, with just 7% in a good ecological condition, and ensure that people across the country had access to wildlife-rich woods.
The 'Biowell' research involved a series of workshops with around 200 people out in woodlands, identifying which traits about woods and their wildlife had an impact on physical, cognitive, emotional, social and spiritual wellbeing.
The researchers then surveyed 10,000 people on how their local wood boosted their wellbeing.
It found sounds, such as birds singing, the scrunching of leaves or trees rustling in the breeze prompted the most positive responses, with 40% getting a wellbeing boost from them, while natural processes such as spring flowers emerging helped 27% of those quizzed, followed by colours with 24%.
The researchers found the trees themselves in a wood gave the biggest wellbeing boost, with silver birch topping the list of positive species ahead of horse chestnut and oak.
Bluetits delivered the best benefits of woodland birds, with blackbirds and chaffinches close behind, while the research also highlighted the benefits of woods in all seasons.
The plants, animals and fungi exhibiting traits that support wellbeing were also mapped to highlight where they would be expected to be found in woods across the country, revealing where people were most likely to be able to access habitats that were good for them.
The mapping highlighted the 'hotspots' in the South East and parts of Scotland, but also found that areas with high levels of deprivation – where people might benefit most from a natural boost to wellbeing – are also often areas where there is a lack of access to wildlife-rich green space.
Zoe Davies, professor of biodiversity conservation at the University of Kent's Durrell Institute of Conservation and Ecology (DICE), said there was plenty of evidence that access to green space was good for people, but it was important to know which species, or their traits delivered the benefits.
'This compelling new research proves that nature is good for us and spending time in biodiverse rich woodland can be a prescription for wellbeing,' she said.
And she told the PA news agency: 'We found that people respond better, get more wellbeing, if there's more biodiversity around them.'
'For most things, for the traits like sound and colour, people respond to diversity.
'That's why it's so important to have these biodiverse forests, because it's the diversity of all these sensory experiences that turned out to be critical.
'It's quality green space, just as importantly as quantity,' she said.
Woodland Trust chief executive Dr Darren Moorcroft said: ''We're in the grip of a biodiversity and human health crisis so it has never been more critical to improve the health of people and the planet.
'Proving that it's good for us to get out among trees and nature means the next step must be ensuring that everyone in the UK has access to vibrant, nature-rich woodland where wildlife – and people and communities – can thrive.'
Sally Bavin, from the Woodland Trust, added: 'This work shows there is stark geographical inequality across the UK in the opportunity for people to witness thriving woodland wildlife and experience the wellbeing lift that brings.
'We think this opportunity should be the right of all,' she said.
She said it helped the trust see where it could deliver woods where they're most needed, pointed to recent purchases such as Harrison Woodlands in Lincolnshire in an area that needs more quality woodland, where the charity will be restoring an ancient woodland currently planted with conifers.
And she said: 'People's mental health is in crisis, biodiversity is in crisis, we could do a lot to help both by restoring woodlands to their glory.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
10 hours ago
- Boston Globe
Jillian Sackler, philanthropist who defended husband's legacy, dies at 84
Arthur Sackler died in 1987 — nine years before the opioid OxyContin was marketed by the company as a powerful painkiller. Shortly after his death, his estate sold his share of the company to his billionaire brothers, Raymond and Mortimer, for $22.4 million. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up The company's misleading advertising claim that OxyContin was nonaddictive prompted doctors to overprescribe it beginning in the 1990s. The proliferation of the medication ruined countless lives of people who became dependent on it. Advertisement In 2021, the company proposed a bankruptcy settlement in which members of the Sackler family agreed to pay $4.2 billion over nine years to resolve civil claims related to the opioid crisis. In return, they sought immunity from future lawsuits. In 2024, the US Supreme Court struck down that deal. A revised settlement was reached in 2025, with the Sacklers and Purdue agreeing to pay $7.4 billion without receiving immunity. The first payment, within three years, included $1.5 billion from the Sacklers and nearly $900 million from Purdue. Advertisement But the backlash from the crisis prompted universities and cultural institutions — including the Louvre and the Metropolitan Museum of Art — to obliterate the Sackler name from programs, buildings, and galleries, and to declare that they would no longer accept any philanthropy from the family. Jillian Sackler — a British native who was made a dame by Queen Elizabeth II in 2005 for her philanthropic work — mounted a concerted publicity campaign to absolve her husband of any complicity or culpability, repeatedly reminding the public that he had died long before the scandal erupted. While she stopped short of saying that the drug was the 'root cause' of the opioid crisis, she accused the company of misleading advertising. She told The Guardian that the other members of the family 'have a moral duty to help make this right and to atone for any mistakes made.' As for Arthur, she added: 'I think he would not have approved of the widespread sale of OxyContin.' The couple were avid art collectors and patrons. One art scholar described Arthur Sackler as 'a modern Medici.' The couple was associated with major cultural and academic institutions like the Arthur M. Sackler Gallery at the Smithsonian Institution; the Sackler Wing at the Metropolitan Museum; the Arthur M. Sackler Museum at Harvard University (now part of the Harvard Art Museums); the Arthur M. Sackler Sciences Center at Clark University; and the Arthur M. Sackler Center for Health Communications and the Sackler School of Graduate Biomedical Sciences, both at Tufts University. After Arthur Sackler died, his wife continued his philanthropic agenda. Donations from his estate and insurance benefits helped finance the Jillian and Arthur M. Sackler Wing of Galleries at the Royal Academy of Arts in London, the Arthur M. Sackler Museum of Art and Archaeology at Peking University, the Arthur M. Sackler Colloquia at the National Academy of Sciences, and Studio International, an art magazine. Their name was removed from some, but not all, of those institutions. Advertisement Gillian Lesley Tully was born on Nov. 17, 1940, in Stoke-on-Trent, in central England south of Manchester. She changed the spelling of her first name when she moved to the United States to be with Arthur Sackler, whom she met in 1967 when he was visiting London; they married in 1980. Her father, Kenneth Tully, worked at Midland Bank (now HSBC UK). He married a colleague, Doris Queenie-Gillman Smith. Ms. Sackler had a younger brother, Brian Tully, who died in 2019, leaving her no immediate survivors except for Arthur Sackler's children from an earlier marriage. Among them is Elizabeth Sackler, a philanthropist who has described the estimated $13 billion amassed by her aunts and cousins during the opioid crisis as 'morally abhorrent.' Jillian Sackler attended New York University. The couple moved into a home on Park Avenue in Manhattan, where she continued to live after her husband's death. In her role as president and CEO of the Dame Jillian and Dr. Arthur M. Sackler Foundation for the Arts, Sciences and Humanities, Sackler referred to the other branches of her husband's family as the 'OxySacklers.' In an opinion piece in The Washington Post in 2019, she wrote that her husband had been smeared through 'guilt by association.' Advertisement 'Neither Arthur nor his heirs had anything to do with the manufacture or marketing of OxyContin,' she asserted. 'Suggestions that his philanthropy is now somehow tainted are simply false.' She added: 'Arthur is not here to answer back, but I can tell you that blaming him for OxyContin's marketing, or for any other wrongdoing by the pharmaceutical industry, is as ludicrous as blaming the inventor of the mimeograph for email spam.' This article originally appeared in
Yahoo
13 hours ago
- Yahoo
L'Oréal to acquire majority stake in British skincare brand Medik8
L'Oréal Group has signed an agreement to acquire a majority stake in UK-based skincare brand Medik8. Inflexion, a European mid-market private equity company, will retain a minority share post-transaction. The acquisition is a strategic move by L'Oréal to bolster its Luxe division with a brand that has a strong foundation in scientific research and innovation. Medik8's performance and potential for international expansion make it a valuable addition to L'Oréal's portfolio. L'Oréal will begin to consolidate Medik8's sales following the transaction's closure. The agreement grants L'Oréal rights to eventually acquire the remaining shares held by minority shareholders. L'Oréal LUXE president Cyril Chapuy stated: 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio. 'We share a strong belief in Medik8's global potential and are excited to embark on this journey together, to build a powerful and impactful brand presence worldwide.' Completion of the transaction is anticipated in the summer or early autumn of 2025, pending regulatory approvals. Founded by scientist Elliot Isaacs, Medik8 is known for its CSA Philosophy: Vitamin C plus Sunscreen by day, Vitamin A by night. Medik8's has expanded its omni-channel sales strategy to include major online and offline retailers in Europe and the US. Medik8 CEO Simon Coble stated: 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' "L'Oréal to acquire majority stake in British skincare brand Medik8" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 hours ago
- Yahoo
Student funding to create generation of AI pioneers
A new scholarship aimed at developing the next generation of artificial intelligence "pioneers" will open to applicants in spring 2026. The Sparck AI scholarships, named after pioneering British computer scientist Karen Sparck Jones, will give master's degree university students access to industry-leading firms as the Government looks to boost the UK's AI credentials. The University of Bristol will be one of nine universities to offer the fully-funded Government scholarship, alongside faculties in Newcastle, Manchester and Edinburgh. The university said they "relish the opportunity," with the grant covering both students tuition and living costs. More news stories for Bristol Watch the latest Points West Listen to the latest news for Bristol The scheme has been developed in line with the Government's 'AI Opportunities Action Plan', with more than £17m of funding from Westminster. Alongside masters places, 100 scholars will receive placements in leading AI companies, as well as mentorship from industry experts. In 2024, Bristol was named 'AI University of the Year' and has developed the Isambard-AI computer - the most powerful of its kind in the country. Vice-chancellor, Evelyn Welch said the scholarships would give Bristol the chance to "explore bold new ideas and nurture exceptional talent." It is hoped the scholarships will give students "unparalleled access" to the fast-moving industry. Technology Secretary Peter Kyle MP said he believed the scheme would help students secure "highly skilled jobs" and build "a workforce fit for the future." Finn Stevenson, Co-founder and Chief Executive of Flok Health said they were "delighted" to be part of the scheme, adding attracting the "world's best talent" was vital in aiding AI advancement in the UK AI talent acquisition firm, Beamery said the scholarships would help their goal to create "equal access to work" and connect "talent to opportunity". Applications open in Spring 2026, with the first cohort beginning studies the following autumn. Follow BBC Bristol on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630.